| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/07/2006 | CN1781906A 半胱氨酸衍生物 Cysteine derivatives |
| 06/07/2006 | CN1781543A Ant oil liniment and its preparing method |
| 06/07/2006 | CN1781537A Shengmai injection and its preparing method |
| 06/07/2006 | CN1781517A Medicine containing zinc element for treating rhinitis and other disease |
| 06/07/2006 | CN1781515A External sterilizing Mongolian medicine lotion for skin and external genital organs |
| 06/07/2006 | CN1781509A Composition of luffa seed oil |
| 06/07/2006 | CN1781488A Polyene phosphatidyl choline infusion solution and its preparing method |
| 06/07/2006 | CN1781487A OCT preparations |
| 06/07/2006 | CN1258533C Antihistaminic spiro compounds |
| 06/07/2006 | CN1258381C Botulinum toxin in the treatment or prevention of acne |
| 06/07/2006 | CN1258378C Medicinal ointment for treating onychomycosis, flat wart and cindyloma acuminatum |
| 06/07/2006 | CN1258374C External-applied traditional Chinese medicine for dispelling toxicity with myogenic function and its preparing method |
| 06/07/2006 | CN1258371C Compositions comprising organic extracts of Geum Japonicum thunb var. and the use thereof |
| 06/07/2006 | CN1258369C Miao medicine plaster for treating skin wound and its preparation |
| 06/07/2006 | CN1258367C Medicine for treating trauma |
| 06/07/2006 | CN1258353C Cosmetic and pharmaceutical composition and its use |
| 06/06/2006 | US7057076 which have improved receptor binding affinity via substituted alkyl side chains at the c-3 position; may contain terpene funtionality combined with resorcinol moieties; for treatment of nervous system disorders and cardiovascular disorders |
| 06/06/2006 | US7057039 Method for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor in a patient in need thereof which comprises providing to said patient a therapeutically effective amount of a compound of formula I |
| 06/06/2006 | US7056944 Pyrazole compositions useful as inhibitors of erk |
| 06/06/2006 | US7056939 4-(4Methoxybenzyl)-n′-(5-nitro1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3 (gsk3) |
| 06/06/2006 | US7056938 Method for scavenging radicals with urocanic acid, derivatives and analogues |
| 06/06/2006 | US7056937 Sulfonylquinoxalone derivatives as bradykinin antagonists |
| 06/06/2006 | US7056904 Therapy for bone disorders; osteoporosis; vitamin deficiency |
| 06/06/2006 | US7056903 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists |
| 06/06/2006 | US7056898 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 06/06/2006 | US7056895 1-(3,4-dihydroxy-5-methylol-tetrahydrofur-2-yl),3-amidino-1H-1,2,4- triazoles; infections, infestations, autoimmune diseases; anticarcinogenic and -tumor agents; HIV, hepatitis C, human papilloma virus and giant cell arteritis |
| 06/06/2006 | US7056885 Fibroblast growth factor and nucleic acids encoding same |
| 06/06/2006 | US7056711 Attenuation of fibroblast proliferation |
| 06/06/2006 | US7056529 Vesicle comprises ATP and phospholipid; fusion proteins |
| 06/06/2006 | US7056500 Polymer conjugates of opioid antagonists |
| 06/06/2006 | CA2457852C Multivesicular emulsion topical delivery systems |
| 06/06/2006 | CA2327723C Bicyclic hydroxamic acid derivatives |
| 06/01/2006 | WO2006058303A2 Modulators of muscarinic receptors |
| 06/01/2006 | WO2006057932A2 2-METHYLENE-18,19-DINOR-1α-HYDROXY-HOMOPREGNACALCIFEROL AND ITS USES |
| 06/01/2006 | WO2006057902A2 2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses |
| 06/01/2006 | WO2006057901A2 2-METHYLENE-19-NOR-1α-HYDROXY-17-ENE-HOMOPREGNACALCIFEROL AND ITS USES |
| 06/01/2006 | WO2006057900A2 17,20(z)-dehydro vitamin d analogs and their uses |
| 06/01/2006 | WO2006057899A2 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses |
| 06/01/2006 | WO2006057886A2 2-METHYLENE-19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND ITS USES |
| 06/01/2006 | WO2006057885A2 17,20(e)-dehydro vitamin d analogs and their uses |
| 06/01/2006 | WO2006057884A2 2α-METHYL AND 2ß-METHYL ANALOGS OF 19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND THEIR USES |
| 06/01/2006 | WO2006057270A1 Nitrogeneous tricyclic compound |
| 06/01/2006 | WO2006057217A1 Dfrp proteins regulating drg proteins and utilization of the same |
| 06/01/2006 | WO2006019353A9 Composition and method for the treatement of psoriasis |
| 06/01/2006 | WO2006018185A8 Dihydropteridinones for the treatment of cancer diseases |
| 06/01/2006 | WO2006014706A3 Methotrexate derivatives useful for treating cancer and arthritis |
| 06/01/2006 | WO2005115365A3 Pharmaceutical or cosmetic composition comprising mequinol and at least one depigmenting agent |
| 06/01/2006 | WO2005107752A3 Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin |
| 06/01/2006 | WO2003025542A3 Immune response associated proteins |
| 06/01/2006 | US20060116518 Novel phenanthridines |
| 06/01/2006 | US20060116516 2-[[4-[[[4-(Aminosulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-4-methyl-5-thiazolecarboxylic acid, ethyl ester; 4-Methyl-2-[[4-[[[4-(methylsulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-5-thiazolecarboxylic acid, ethyl ester; Antiinflammatory agents; rheumatic diseases |
| 06/01/2006 | US20060116388 CXCR3 antagonists |
| 06/01/2006 | US20060116385 Novel compounds having selective inhibiting effect at gsk3 |
| 06/01/2006 | US20060116381 4-4(methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-ben-zamide for treating mutated-ret kinase associated diseases |
| 06/01/2006 | US20060116362 Nobel compounds having selective inhibiting effect at gsk3 |
| 06/01/2006 | US20060115480 Disease treatment via antimicrobial peptide inhibitors |
| 06/01/2006 | US20060115452 Uses of interleukin-18 for treating skin disorders associated with uv radiations |
| 06/01/2006 | US20060115376 Irradiation in presence of stabilizer; preventing degradation |
| 06/01/2006 | US20060113968 Novel benzonaphthyridines |
| 06/01/2006 | DE19849107B4 Verfahren zur Entfernung von unerwünschten, endogen vorhandenen toxischen Alkaloiden aus Pflanzen oder aus pflanzlichen Zubereitungen A method for removing unwanted endogenously present toxic alkaloids from plants or herbal preparations |
| 06/01/2006 | DE102004057303A1 Stabile Kristallmodifikationen von DOTAP Chlorid Stable crystal modifications of DOTAP chloride |
| 06/01/2006 | CA2589439A1 Modulators of muscarinic receptors |
| 06/01/2006 | CA2588412A1 2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses |
| 06/01/2006 | CA2588406A1 2-.alpha.-methyl and 2-.beta.-methyl analogs of 19,26,27-trinor-(20s-1.alpha.-hydroxyvitamin d3 and their uses |
| 06/01/2006 | CA2588401A1 17,20(z)-dehydro vitamin d analogs and their uses |
| 06/01/2006 | CA2588399A1 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses |
| 06/01/2006 | CA2588396A1 17,20(e)-dehydro vitamin d analogs and their uses |
| 06/01/2006 | CA2579962A1 Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders |
| 05/31/2006 | EP1661897A1 Pyrrolopyrimidinone derivative |
| 05/31/2006 | EP1661896A1 Pyrrolopyrimidinethione derivative |
| 05/31/2006 | EP1661889A1 Chemokine receptor antagonist and medical use thereof |
| 05/31/2006 | EP1661878A1 Adapalene polymorphic forms |
| 05/31/2006 | EP1661578A1 Skin ulcer preventive curative agent containing human recombinant hgf |
| 05/31/2006 | EP1661565A1 Composition for the treatment of vitiligo |
| 05/31/2006 | EP1660475A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 05/31/2006 | EP1660467A2 Aminofurazan compounds as protein kinase inhibitors |
| 05/31/2006 | EP1660127A1 Antibodies to c-met |
| 05/31/2006 | EP1660114A1 Methods and compositions for treating disorders of the extracellular matrix |
| 05/31/2006 | EP1660102A1 New therapeutic use of chondroitin sulphate |
| 05/31/2006 | EP1660093A1 Ammonium salts of ornithine derivatives for treating inflammatory diseases |
| 05/31/2006 | EP1660085A1 Pyridylpyrrole derivatives active as kinase inhibitors |
| 05/31/2006 | EP1660068A1 Composition for treatment of tinea pedis and method of use |
| 05/31/2006 | EP1420824B1 Sulfonated chlorines as photosensitizer |
| 05/31/2006 | EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1318997B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317449B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317444B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1315500A4 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 05/31/2006 | EP1272156B1 Use of alcohol dehydrogenase inhibitors for cosmetic treatment of keratinous materials |
| 05/31/2006 | EP1268798B1 Anti-angiogenic properties of vascostatin and fragments or variants thereof |
| 05/31/2006 | EP1235851B1 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 05/31/2006 | EP1221957B1 Method for preparing a composition by mother-of-pearl extraction,and use thereof in cosmetics and dermatology |
| 05/31/2006 | EP1163238B1 Chemokine recpetor binding heterocyclic compounds |
| 05/31/2006 | EP0757717B1 Papillomavirus vaccines |
| 05/31/2006 | CN1780856A Human antibodies specific for interleukin 15 (IL-15) |
| 05/31/2006 | CN1780840A Pyrazolo 1,5-a pyrimidine derivatives |
| 05/31/2006 | CN1780620A Use of a topical medicament comprising riluzole |
| 05/31/2006 | CN1778378A Production of externally-applied for treating acne |
| 05/31/2006 | CN1778361A Medicinal spirit for nail-like boil |
| 05/31/2006 | CN1778360A Burn and scald medicine |